The injection of CIS markedly increased cardiac MPO enzymatic activity and cardiac cytokines TNF-α, IL-1β, and IL-6 levels, as well as NF-κB expression either mRNA or nuclear translocation, compared with normal control rats. The gene discussed is NFKB1; the disease is in situ carcinoma.